Switching Medication to Treat Schizophrenia

StatusCompleted
PhasePhase 4
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoint revisedv16
  2. Enrollment target: 280 to 219
    • Study sites: 16 to 0
    v15
  3. Re-verified, no change to tracked fieldsv14
  4. Lead sponsor: National Institute of Mental Health (NIMH) to Icahn School of Medicine at Mount Sinaiv13 Show 9 more changesShow less
    • Results first posted: Dec 5, 2013
    • Primary endpoint revised
    • Trial status: Active, Not Recruiting to Completed
    • Enrollment target: estimated 300 to confirmed 280
    • Primary completion date changed from estimate of Apr 2009 to Mar 2009
    • Study completion date changed from estimate of May 2009 to Mar 2009
    • Secondary endpoint revised
    • Collaborators expanded, about 6 words
    • Publications: details revised at 2 of 2 entries
  5. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 16 of 16 sites
    v12
Show 10 earlier versionsHide 10 earlier versions
  1. Primary completion date: Apr 2009
    • Study completion date: May 2009
    • Site details revised at 7 of 16 sites
    • Study arms: 0 to 2
    v11
  2. Site contacts updated at 2 of 16 sitesv10
  3. Site contacts updated at 1 of 16 sitesv9
  4. Site details revised at 1 of 16 sitesv8
  5. Study sites: 17 to 16
    • Eligibility criteria revised
    v7
  6. Study sites: 14 to 17v6
  7. Study sites: 12 to 14
    • Study description revised
    v5
  8. Re-verified, no change to tracked fieldsv4
  9. Study sites: 13 to 12v3
  10. Study sites: 1 to 13
    • Start date: Jul 2001
    • Study description expanded, about 77 words
    • Eligibility criteria expanded, about 1 word
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia.
Trial Details
NCT Number NCT00044655
Lead Sponsor Icahn School of Medicine at Mount Sinai
Collaborators: National Institute of Mental Health (NIMH)
Conditions
(from sponsor)		 Schizophrenia
Related terms Schizophrenia
Enrollment 219 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov